Natural products in anticancer therapy
- 17 July 2001
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Pharmacology
- Vol. 1 (4), 364-369
- https://doi.org/10.1016/s1471-4892(01)00063-7
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current statusExpert Opinion on Investigational Drugs, 2000
- Medicines from nature: are natural products still relevant to drug discovery?Trends in Pharmacological Sciences, 1999
- Discovery and Development of Antineoplastic Agents from Natural SourcesCancer Investigation, 1999
- Natural Products in Drug Discovery and DevelopmentJournal of Natural Products, 1997
- Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicatesCancer Letters, 1996
- Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275Biochemical and Biophysical Research Communications, 1994
- Acute effects of 4-ipomeanol on experimental lung tumors with bronchiolar or alveolar cell features in Syrian hamsters or C3H/HeNCr miceZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Metabolism of plant-derived anticancer agentsPharmacology & Therapeutics, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideThe New England Journal of Medicine, 1987
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsEuropean Journal of Cancer (1965), 1973